Noticias de LLY_US

Noticias del mercado

Últimas noticias sobre LLY_US — 502 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: LLY_US ✕ 502 resultados
28/03/2026 LLY_US — investor.lilly.com
Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity | Eli Lilly and Company
27/03/2026 LLY_US — investor.lilly.com ES ← EN
EBGLYSS (lebrikizumab-lbkz) de Lilly proporcionó hasta cuatro años de control duradero de la enfermedad en pacientes con dermatitis atópica de moderada a grave | Eli Lilly y compañía
25/03/2026 LLY_US — Healthcare Digital
What is in Eli Lilly & Company’s 2025 Year in Review Report?
25/03/2026 LLY_US — Yahoo Finance
Is Eli Lilly (LLY) The Best Healthcare Stock to Buy According to Jim Cramer?
22/03/2026 LLY_US — Yahoo Finance
Eli Lilly and Company (LLY) Expands Zepbound Access as Pricing Reforms Boost Long-Term Growth Outlook
19/03/2026 LLY_US — investor.lilly.com
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes
19/03/2026 LLY_US — Reuters
Lilly's next-gen drug shows significant blood sugar, weight reduction in diabetes trial
18/03/2026 LLY_US — Yahoo Finance
Eli Lilly and Company (LLY) Gets Downgraded to Reduce From Hold by HSBC – Here’s Why
16/03/2026 LLY_US — Yahoo Finance
Wall Street Firms Turn Bullish on Eli Lilly and Company (LLY) Buoyed by GLP-1 Medication Expansion Plans
15/03/2026 LLY_US — Yahoo Finance
Is Eli Lilly and Company (LLY) A Good Stock To Buy Now?
12/03/2026 LLY_US — investor.lilly.com
An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12
11/03/2026 LLY_US — MLB.com
Durham Bulls Announce Extension of Partnership with Eli Lilly and Company
10/03/2026 LLY_US — Yahoo Finance
Eli Lilly and Company (LLY) Set to Launch Oral Obesity Drug in Q2, Reuters Reports
10/03/2026 LLY_US — Yahoo Finance
Eli Lilly and Company (LLY) Announces the Launch of its Employer Connect Platform
09/03/2026 LLY_US — investor.lilly.com ES ← EN
Actualizado: Declaración de Lilly sobre el modelo CMMI BALANCE para medicamentos GLP-1 y el modelo puente GLP-1 de Medicare
05/03/2026 LLY_US — investor.lilly.com
Lilly Employer Connect platform launches with over fifteen independent program administrators offering tailored obesity coverage options to expand access to patients
03/03/2026 LLY_US — Yahoo Finance
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
26/02/2026 LLY_US — investor.lilly.com
Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet | Eli Lilly and Company

Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet | Eli Lilly and…

23/02/2026 LLY_US — investor.lilly.com
Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen
18/02/2026 LLY_US — Yahoo Finance
Eli Lilly and Company (LLY) Gains as Medicare Expansion of GLP-1 Weight Loss Drugs Eases Pricing Concerns

Página 25 de 26

keyboard_arrow_up